{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:39:25Z","timestamp":1781933965274,"version":"3.54.5"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007109","name":"University of Ferrara","doi-asserted-by":"publisher","award":["FAR2023"],"award-info":[{"award-number":["FAR2023"]}],"id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PE00000006 CUP H93C22000660006"],"award-info":[{"award-number":["PE00000006 CUP H93C22000660006"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.pnpbp.2025.111342","type":"journal-article","created":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T15:39:41Z","timestamp":1742917181000},"page":"111342","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Kynurenine amplifies tetrahydrocannabinol-induced sensorimotor impairment and classic \u201ctetrad\u201d effects in mice"],"prefix":"10.1016","volume":"138","author":[{"given":"Sabrine","family":"Bilel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Corli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Tiziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Chirenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Dall'Acqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Comai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Ferraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Marti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Beggiato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.pnpbp.2025.111342_bb0005","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00213-021-05852-5","article-title":"Comparison of N-methyl-2-pyrrolidone (NMP) and the \"date rape\" drug GHB: behavioral toxicology in the mouse model","volume":"238","author":"Arf\u00e8","year":"2021","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111342_bb0010","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41583-021-00465-5","article-title":"Cannabis and synaptic reprogramming of the developing brain","volume":"22","author":"Bara","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111342_bb0015","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00213-024-06526-8","article-title":"Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice-from a human poisoning case to the preclinical evidence","volume":"241","author":"Bassi","year":"2024","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.nlm.2016.12.023","article-title":"Long-lasting alterations of hippocampal GABAergic neurotransmission in adult rats following perinatal \u03949-THC exposure","volume":"139","author":"Beggiato","year":"2017","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109883","article-title":"Prenatal THC exposure raises kynurenic acid levels in the prefrontal cortex of adult rats","volume":"100","author":"Beggiato","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0030","article-title":"Alterations in rat prefrontal cortex kynurenic acid levels are involved in the enduring cognitive dysfunctions induced by tetrahydrocannabinol exposure during the adolescence","volume":"13","author":"Beggiato","year":"2022","journal-title":"Front. Psychol."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108110","article-title":"In vitro and in vivo pharmacological characterization of the synthetic opioid MT-45","volume":"171","author":"Bilel","year":"2020","journal-title":"Neuropharmacology"},{"issue":"14","key":"10.1016\/j.pnpbp.2025.111342_bb0040","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.3390\/ijms22147659","article-title":"In vitro and in vivo Pharmaco-toxicological characterization of 1-Cyclohexyl-x-methoxybenzene derivatives in mice: comparison with tramadol and PCP","volume":"22","author":"Bilel","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0045","article-title":"In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl","volume":"209","author":"Bilel","year":"2022","journal-title":"Ocfentanyl and Furanylfentanyl. Neuropharmacol."},{"issue":"21","key":"10.1016\/j.pnpbp.2025.111342_bb0050","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1111\/bph.16164","article-title":"Cognitive dysfunction and impaired neuroplasticity following repeated exposure to the synthetic cannabinoid JWH-018 in male mice","volume":"180","author":"Bilel","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.brainresbull.2006.12.009","article-title":"Differential effects of exposure to low-light or high-light open-field on anxiety-related behaviors: relationship to c-Fos expression in serotonergic and non-serotonergic neurons in the dorsal raphe nucleus","volume":"72","author":"Bouwknecht","year":"2007","journal-title":"Brain Res. Bull."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111342_bb0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.ALC.0000156116.40817.A2","article-title":"Deletion of the alpha7 nicotinic receptor subunit gene results in increased sensitivity to several behavioral effects produced by alcohol","volume":"29","author":"Bowers","year":"2005","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"18","key":"10.1016\/j.pnpbp.2025.111342_bb0065","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1007\/s00213-014-3509-2","article-title":"Effects of the nicotinic alpha7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in rats","volume":"231","author":"Callahan","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2024.111058","article-title":"Therapeutic modulation of the kynurenine pathway in severe mental illness and comorbidities: A potential role for serotonergic psychedelics","volume":"134","author":"Campanale","year":"2024","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"21\u221222","key":"10.1016\/j.pnpbp.2025.111342_bb0075","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1007\/s00213-016-4402-y","article-title":"Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on \u201ctetrad\u201d, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies","volume":"233","author":"Canazza","year":"2016","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111342_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2601","article-title":"Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies","volume":"32","author":"Canazza","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2023.116382","article-title":"Effect of pharmacological modulation of the kynurenine pathway on pain-related behavior and opioid analgesia in a mouse model of neuropathic pain","volume":"461","author":"Ciapa\u0142a","year":"2023","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2021.108766","article-title":"Covid-19 interface with drug misuse and substance use disorders","volume":"198","author":"Cisneros","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0095","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-319-28383-8_10","article-title":"Cannabinoids: glutamatergic transmission and kynurenines","volume":"12","author":"Col\u00edn-Gonz\u00e1lez","year":"2016","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12916-024-03248-8","article-title":"Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms","volume":"22","author":"Comai","year":"2024","journal-title":"BMC Med."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0105","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-3565(25)11216-0","article-title":"Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents","volume":"260","author":"Compton","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111342_bb0115","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/npp.2017.140","article-title":"Sex-dependent effects of Cannabis and cannabinoids: A translational perspective","volume":"43","author":"Cooper","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111342_bb0120","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00213-023-06378-8","article-title":"MAM-2201 acute administration impairs motor, sensorimotor, prepulse inhibition, and memory functions in mice: a comparison with its analogue AM-2201","volume":"240","author":"Corli","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176486","article-title":"5-HT2A receptors are involved in the pharmaco-toxicological effects of the synthetic cannabinoids JWH-018 and 5F-PB22: in vivo studies in mice","volume":"971","author":"Corli","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111342_bb0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/15504263.2023.2293854","article-title":"Integrative pharmacology in the treatment of substance use disorders","volume":"20","author":"Donlon","year":"2024","journal-title":"J. Dual Diagn."},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111342_bb0135","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1080\/15622975.2022.2038797","article-title":"Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis","volume":"23","author":"D\u2019Souza","year":"2022","journal-title":"World J. Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.pnpbp.2025.111342_bb0140","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.biopsych.2016.12.011","article-title":"2017. Adaptive and behavioral changes in kynurenine 3-monooxygenase knockout mice: relevance to psychotic disorders","volume":"82","author":"Erhardt","year":"2017","journal-title":"Biol Psychiatry."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111342_bb0145","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/brainsci10090606","article-title":"Sex and gender differences in the effects of novel psychoactive substances","volume":"10","author":"Fattore","year":"2020","journal-title":"Brain Sci."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111342_bb0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111342_bb0155","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s43440-024-00604-6","article-title":"Prenatal MAM exposure raises kynurenic acid levels in the prefrontal cortex of adult rats","volume":"76","author":"Frescura","year":"2024","journal-title":"Pharmacol. Rep."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111342_bb0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.biopsych.2015.08.001","article-title":"Association between cannabis and psychosis: epidemiologic evidence","volume":"79","author":"Gage","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109689","article-title":"Acute administration of the NMDA receptor antagonists ketamine and MK-801 reveals dysregulation of glutamatergic signalling and sensorimotor gating in the Sapap3 knockout mouse model of compulsive-like behaviour","volume":"239","author":"Gattuso","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0170","first-page":"121","article-title":"The stoned age: sex differences in the effects of adolescent cannabinoid exposure on prefrontal cortex structure and function in animal models","volume":"161","author":"Ginder","year":"2022","journal-title":"Int. Rev. Neurobiol."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111342_bb0175","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.biopsych.2013.12.002","article-title":"The cytokine model of schizophrenia: emerging therapeutic strategies","volume":"75","author":"Girgis","year":"2014","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111342_bb0180","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2022.11.003","article-title":"Inflammation-related functional and structural Dysconnectivity as a pathway to psychopathology","volume":"93","author":"Goldsmith","year":"2023","journal-title":"Biol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111342_bb0185","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/cpt.3381","article-title":"Cannabidiol increases psychotropic effects and plasma concentrations of delta(9)-tetrahydrocannabinol without improving its analgesic properties","volume":"116","author":"Gorbenko","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104434","article-title":"Role of the kynurenine pathway and the endocannabinoid system as modulators of inflammation and personality traits","volume":"110","author":"Heilman","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111342_bb0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0304-3940(98)00802-7","article-title":"Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2","volume":"257","author":"Hohmann","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0200","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jat\/16.5.276","article-title":"Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana","volume":"16","author":"Huestis","year":"1992","journal-title":"J. Anal. Toxicol."},{"issue":"42","key":"10.1016\/j.pnpbp.2025.111342_bb0205","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1523\/JNEUROSCI.1165-19.2019","article-title":"Cannabis and the developing brain: insights into its long-lasting effects","volume":"39","author":"Hurd","year":"2019","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111342_bb0210","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/nn.3540","article-title":"Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid","volume":"16","author":"Justinova","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0215","doi-asserted-by":"crossref","first-page":"12031","DOI":"10.1523\/JNEUROSCI.0630-17.2017","article-title":"Phencyclidine Discoordinates hippocampal network activity but not place fields","volume":"37","author":"Kao","year":"2017","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111342_bb0220","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/npp.2014.326","article-title":"The sleep-promoting and hypothermic effects of glycine are mediated by NMDA receptors in the suprachiasmatic nucleus","volume":"40","author":"Kawai","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111342_bb0225","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111342_bb0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0304-3940(94)90129-5","article-title":"Competitive NMDA antagonists enhance the catalepsy induced by delta 9-tetrahydrocannabinol in mice","volume":"174","author":"Kinoshita","year":"1994","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111342_bb0235","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00213-008-1160-5","article-title":"Cataleptic effects of gamma-hydroxybutyrate (GHB) and baclofen in mice: mediation by GABA(B) receptors, but differential enhancement by N-methyl-d-aspartate (NMDA) receptor antagonists","volume":"199","author":"Koek","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0240","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s10517-015-3054-y","article-title":"Nociceptive reactions in rats during repeated stress exposure","volume":"159","author":"Kozlov","year":"2015","journal-title":"Bull. Exp. Biol. Med."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0245","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3389\/fimmu.2020.00249","article-title":"Inflammation-induced tryptophan breakdown is related with Anemia, fatigue, and depression in Cancer","volume":"11","author":"Lanser","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111342_bb0250","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41398-021-01610-5","article-title":"Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms","volume":"11","author":"Leclercq","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111342_bb0255","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0006-8993(91)90017-P","article-title":"Cannabinoid-induced antinociception is mediated by a spinal alpha 2-noradrenergic mechanism","volume":"559","author":"Lichtman","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0260","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brainres.2005.07.033","article-title":"Morphine has an antinociceptive effect through activation of the okadaic-acid-sensitive Ser\/Thr protein phosphatases PP 2 A and PP5 estimated by tail-pinch test in mice","volume":"1056","author":"Maeda","year":"2005","journal-title":"Brain Res."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0265","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1523\/JNEUROSCI.0987-04.2004","article-title":"Blockade of nociceptin\/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior","volume":"24","author":"Marti","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0270","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.1523\/JNEUROSCI.2546-05.2005","article-title":"Blockade of nociceptin\/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson\u2019s disease","volume":"25","author":"Marti","year":"2005","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111342_bb0275","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(98)00044-5","article-title":"Cannabinoid receptor-mediated inhibition of the rat tail-flick reflex after microinjection into the rostral ventromedial medulla","volume":"242","author":"Martin","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0280","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.euroneuro.2018.12.003","article-title":"Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity","volume":"29","author":"Mason","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2025.111342_bb0285","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/acer.14920","article-title":"Tryptophan-kynurenine metabolism during acute alcohol withdrawal in patients with alcohol use disorder: the role of immune activation","volume":"46","author":"Mechtcheriakov","year":"2022","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0290","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4137\/IJTR.S26862","article-title":"Tryptophan catabolism in chronic viral infections: handling uninvited guests","volume":"8","author":"Mehraj","year":"2015","journal-title":"Int. J. Tryptophan Res."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0295","series-title":"Neurobiology of the Kynurenine Pathway and cannabis Misuse: A New Narrative in Cannabis Use, Neurobiology, Psychology, and Treatment","first-page":"265","author":"Morales-Puerto","year":"2023"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107807","article-title":"Addiction and the kynurenine pathway: A new dancing couple?","volume":"223","author":"Morales-Puerto","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0305","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fnins.2015.00372","article-title":"The role of inflammation in schizophrenia","volume":"9","author":"M\u00fcller","year":"2015","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.pnpbp.2025.111342_bb0310","doi-asserted-by":"crossref","first-page":"507","DOI":"10.9758\/cpn.2020.18.4.507","article-title":"Kynurenine pathway of tryptophan metabolism in neuropsychiatric disorders: pathophysiologic and therapeutic considerations","volume":"18","author":"Muneer","year":"2020","journal-title":"Clin. Psychopharmacol. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111342_bb0315","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.bbr.2010.11.053","article-title":"Pharmacological characterizations of memantine-induced disruption of prepulse inhibition of the acoustic startle response in mice: involvement of dopamine D2 and 5-HT2A receptors","volume":"218","author":"Nakaya","year":"2011","journal-title":"Behav. Brain Res."},{"issue":"408","key":"10.1016\/j.pnpbp.2025.111342_bb0320","article-title":"Multiple nicotinic acetylcholine receptor subtypes regulate social or cognitive behaviors in mice repeatedly administered phencyclidine","volume":"25","author":"Noda","year":"2021","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0325","doi-asserted-by":"crossref","unstructured":"Olsson, S.K., Andersson, A.S., Linderholm, K.R., Holtze, M., Nilsson-Todd, L.K., Schwieler, L., Olsson, E., Larsson, K., Engberg, G., Erhardt, S., 2009. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia. Int. J.Neuropsychopharmacology 12(4):501\u2013512. doi: https:\/\/doi.org\/10.1017\/S1461145708009383.","DOI":"10.1017\/S1461145708009383"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0330","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.neuroscience.2015.05.021","article-title":"JWH-018 impairs sensorimotor functions in mice","volume":"300","author":"Ossato","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0335","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.pnpbp.2016.01.007","article-title":"Effect of JWH-250, JWH-073 and their interaction on \"tetrad\", sensorimotor, neurological and neurochemical responses in mice","volume":"67","author":"Ossato","year":"2016","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0340","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/cpt.118","article-title":"Cannabinoid abuse and addiction: clinical and preclinical findings","volume":"97","author":"Panlilio","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0345","article-title":"Acute kynurenine challenge disrupts sleep-wake architecture and impairs contextual memory in adult rats","volume":"40(11):zsx141","author":"Pocivavsek","year":"2017","journal-title":"Sleep"},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111342_bb0350","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1124\/pharmrev.124.000239","article-title":"Neuroactive kynurenines as pharmacological targets: new experimental tools and exciting therapeutic opportunities","volume":"76","author":"Pocivavsek","year":"2024","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111342_bb0355","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1177\/0269881116675509","article-title":"Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats","volume":"31","author":"Potasiewicz","year":"2017","journal-title":"J. Psychopharmacol."},{"issue":"1\u20133","key":"10.1016\/j.pnpbp.2025.111342_bb0360","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-2999(96)00045-3","article-title":"A role for central cannabinoid and opioid systems in peripheral delta 9-tetrahydrocannabinol-induced analgesia in mice","volume":"301","author":"Reche","year":"1996","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2025.111342_bb0365","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.14038","article-title":"Reducing brain kynurenic acid synthesis precludes kynurenine-induced sleep disturbances","volume":"33","author":"Rentschler","year":"2024","journal-title":"J. Sleep Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111342_bb0370","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S1526-5900(00)90082-8","article-title":"Cannabinoids modulate pain by multiple mechanisms of action","volume":"1","author":"Richardson","year":"2000","journal-title":"J. Pain"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111342_bb0375","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1523\/JNEUROSCI.18-01-00451.1998","article-title":"Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia","volume":"18","author":"Richardson","year":"1998","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111342_bb0380","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pharep.2018.10.002","article-title":"Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model","volume":"71","author":"Rojewska","year":"2019","journal-title":"Pharmacol. Rep."},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111342_bb0385","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/ijnp\/pyad055","article-title":"Sex differences in plasma, adipose tissue, and central accumulation of cannabinoids, and behavioral effects of Oral Cannabis consumption in male and female C57BL\/6 mice","volume":"26","author":"Sallam","year":"2023","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.pnpbp.2025.111342_bb0390","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/schbul\/sbq112","article-title":"Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia","volume":"37","author":"Sathyasaikumar","year":"2011","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0395","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/bs.apha.2016.01.005","article-title":"Kynurenines and glutamate: multiple links and therapeutic implications","volume":"76","author":"Schwarcz","year":"2016","journal-title":"Adv. Pharmacol."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111342_bb0400","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0006-3223(01)01078-2","article-title":"Increased cortical kynurenate content in schizophrenia","volume":"50","author":"Schwarcz","year":"2001","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111342_bb0405","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrn3257","article-title":"Kynurenines in the mammalian brain: when physiology meets pathology","volume":"13","author":"Schwarcz","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"issue":"8","key":"10.1016\/j.pnpbp.2025.111342_bb0410","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1038\/npp.2017.21","article-title":"Attenuating nicotine reinforcement and relapse by enhancing endogenous brain levels of Kynurenic acid in rats and squirrel monkeys","volume":"42","author":"Secci","year":"2017","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111342_bb0415","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1007\/s12035-018-1319-y","article-title":"Astrocytic mechanisms involving Kynurenic acid control \u03949-tetrahydrocannabinol-induced increases in glutamate release in brain reward-processing areas","volume":"56","author":"Secci","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.pnpbp.2025.111342_bb0420","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/ph14070668","article-title":"Pharmacokinetic properties of the novel synthetic cannabinoid 5F-APINAC and its influence on metabolites associated with neurotransmission in rabbit plasma","volume":"14","author":"Shestakova","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0425","doi-asserted-by":"crossref","unstructured":"Swartz, K.J., During, M.J., Freese, A., Beal, M.F., 1990. Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. J. Neurosci. 10:2965\u20132973. doi: https:\/\/doi.org\/10.1523\/JNEUROSCI.10-09-02965.","DOI":"10.1523\/JNEUROSCI.10-09-02965.1990"},{"issue":"23","key":"10.1016\/j.pnpbp.2025.111342_bb0430","doi-asserted-by":"crossref","first-page":"13032","DOI":"10.3390\/ijms222313032","article-title":"Role and perspectives of inflammation and C-reactive protein (CRP) in psychosis: an economic and widespread tool for assessing the disease","volume":"22","author":"Ullah","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0435","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/cercor\/bhv018","article-title":"NMDA receptor antagonist ketamine distorts object recognition by reducing feedback to early visual cortex","volume":"26","author":"van Loon","year":"2016","journal-title":"Cereb. Cortex"},{"issue":"5","key":"10.1016\/j.pnpbp.2025.111342_bb0440","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/mp.2016.252","article-title":"Cannabis use and risk of schizophrenia: A Mendelian randomization study","volume":"23","author":"Vaucher","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0445","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuropharm.2015.02.008","article-title":"Novel halogenated derivates of JWH-018: behavioral and binding studies in mice","volume":"95","author":"Vigolo","year":"2015","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.pnpbp.2025.111342_bb0450","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.chc.2022.07.004","article-title":"Cannabis and psychosis","volume":"32","author":"West","year":"2023","journal-title":"Child Adolesc. Psychiatr. Clin. N. Am."},{"key":"10.1016\/j.pnpbp.2025.111342_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.110145","article-title":"Gut microbiota, kynurenine pathway and mental disorders","volume":"106","author":"Wi\u0119d\u0142ocha","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2025.111342_bb0460","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/schbul\/sbq002","article-title":"Cortical kynurenine pathway metabolism: a novel target for cognitive enhancement in schizophrenia","volume":"36","author":"Wonodi","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"20","key":"10.1016\/j.pnpbp.2025.111342_bb0465","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.3390\/molecules24203709","article-title":"Kynurenines and the endocannabinoid system in schizophrenia: common points and potential interactions","volume":"24","author":"Z\u00e1dor","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.pnpbp.2025.111342_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104752","article-title":"Long-term systemic administration of kynurenic acid brain region specifically elevates the abundance of functional CB1 receptors in rats","volume":"138","author":"Z\u00e1dor","year":"2020","journal-title":"Neurochem. Int."},{"issue":"11","key":"10.1016\/j.pnpbp.2025.111342_bb0475","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.3390\/ijms22115903","article-title":"Pro-inflammatory cytokines: potential links between the endocannabinoid system and the kynurenine pathway in depression","volume":"22","author":"Z\u00e1dor","year":"2021","journal-title":"Int. J. Mol. Sci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462500096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462500096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T19:25:19Z","timestamp":1762284319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858462500096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":94,"alternative-id":["S027858462500096X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111342","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kynurenine amplifies tetrahydrocannabinol-induced sensorimotor impairment and classic \u201ctetrad\u201d effects in mice","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2025.111342","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111342"}}